You are here

Michel Vounatsos

Vounatsos Out as Biogen Appears to Concede Defeat Over Aduhelm

BioSpace

Tue, 05/3/22 - 10:52 am

Michel Vounatsos

Biogen CEO's 2021 pay remains level despite Aduhelm tribulations

Fierce Pharma

Fri, 04/29/22 - 10:38 am

Michel Vounatsos

Biogen's Michel Vounatsos takes home $18.7M in pay as the company battles to take aducanumab to market

Endpoints

Tue, 04/27/21 - 10:48 am

Michel Vounatsos

Thanks to Spinraza and biosims—if not aducanumb—Biogen CEO Vounatsos scored $18M+ in 2019 pay

Fierce Pharma

Tue, 04/21/20 - 12:15 pm

Michel Vounatsos

Biogen CEO Vounatsos scores $2.5M raise amid investor demands for a new strategy

Fierce Pharma

Thu, 05/2/19 - 11:07 am

Michel Vounatsos

5 Things Biogen's CEO Just Said That You Don't Want to Miss

Motley Fool

Wed, 03/8/17 - 10:07 am

Michel Vounatsos

Investors see Biogen CEO choice as friendly to potential takeover

Yahoo/Reuters

Wed, 12/21/16 - 11:12 am

Michel Vounatsos

Here's Why Investors Weren't Excited About Biogen's New CEO

Fortune

Tue, 12/20/16 - 12:46 pm

Michel Vounatsos